Richard Glynne

Director Ejecutivo en

Belharra Therapeutics, Inc.

Health Technology

Commercial Services

Finance

Perfil

Dr. Richard Glynne is a Chief Executive Officer at Belharra Therapeutics, Inc., a CSO at Inception Sciences, Inc. and a Venture Partner at Versant Venture Management LLC.
Dr. Glynne was previously employed as an Associate by NewCo /Ca/, an Executive Director by Novartis Institutes for Biomedical Research, Inc., an Executive Director of Genetics by Novartis AG, a VP Genetics by Phenomix Corp., and a Director Genomics by EOS Biotechnology, Inc. He received his doctorate degree from Imperial Cancer Research Fund Trading Ltd..

Cargos activos de Richard Glynne

Empresas	Cargo	Inicio
Versant Venture Management LLC Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements.	Inversor de Capital Privado	01/01/2018
Inception Sciences, Inc. Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services	Corporate Officer/Principal	01/11/2018
Belharra Therapeutics, Inc. Belharra Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a ?drug discovery company	Director Ejecutivo	01/01/2025

Todos los cargos activos de Richard Glynne

Antiguos cargos conocidos de Richard Glynne.

Empresas	Cargo	Fin
NewCo /Ca/ NewCo /Ca/ Food DistributorsDistribution Services Distributes pet food	Corporate Officer/Principal	01/11/2018
Novartis Institutes for Biomedical Research, Inc. Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches	Inversor de Capital Privado	01/01/2018
NOVARTIS AG	Inversor de Capital Privado	01/01/2015
Phenomix Corp. Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs	Inversor de Capital Privado	01/01/2004
EOS Biotechnology, Inc. EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs	Corporate Officer/Principal	01/01/2002

Ver el detalle de la experiencia de Richard Glynne.

Formación de Richard Glynne.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Richard Glynne.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	9
Phenomix Corp. Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs	Health Technology
Novartis AG Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products	Health Technology
EOS Biotechnology, Inc. EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic and diagnostic drugs	Health Technology
Versant Venture Management LLC Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements.	Finance
Novartis Institutes for Biomedical Research, Inc. Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches	Commercial Services
Imperial Cancer Research Fund Trading Ltd. Imperial Cancer Research Fund Trading Ltd. Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Inception Sciences, Inc. Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services	Health Technology
NewCo /Ca/ NewCo /Ca/ Food DistributorsDistribution Services Distributes pet food	Distribution Services
Belharra Therapeutics, Inc. Belharra Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a ?drug discovery company	Commercial Services